MacroGenics
MGNX
#9309
Rank
NZ$0.27 B
Marketcap
NZ$4.31
Share price
3.86%
Change (1 day)
69.63%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.27 Billion

As of November 2026 MacroGenics has a market cap of NZ$0.27 Billion. This makes MacroGenics the world's 9309th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.27 B56.16%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.26 Billion
by Nasdaq info icon info icon
NZ$0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$295.32 B 107,441.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.211 T 805,092.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$441.67 B 160,735.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$371.02 B 135,009.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$644.86 B 234,727.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$225.61 B 82,058.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$4.95 B 1,704.99%๐Ÿ‡บ๐Ÿ‡ธ USA